Is a complete CNSY research report available?

No complete published report is available for Cerenome, Inc. (CNSY) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Cerenome, Inc. (CNSY)

NASDAQ: CNSY · USD

$3.83

-0.03 (-0.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-08 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CNSY analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	26.4M
Revenue (ttm)	5.2M
Net income (ttm)	-11.9M
EPS (ttm)	-$2.62
Shares out	6.9M
Volume	68,286
Beta	1.42
Price target	$36.0	+839.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.2M
Net income (ttm): -11.9M
EPS (ttm): -$2.62
Market cap: 26.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	29.6B	39.4x	6.2x	96.6%	+47.5%	-49.6%	Strong Buy
ARGX	argenx SE	54.1B	31.5x	10.2x	50.6%	+58.8%	+30.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CNSY indicators

Market & fundamental data

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Company name	Cerenome, Inc.
Country	United States
Country code	US
Cusip	72941H806
Employees	28
Employees Change	7%
Employees Change Percent	33.33
Enterprise value	$12M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-08-04
Industry	Medical - Pharmaceuticals
Isin	US72941H8060
Last refreshed	2026-08-08
Market cap	$26.4M
Market cap category	Nano-Cap
Price	$3.83
Price currency	USD
Rev Per Employee	185,071.43x
Sector	Healthcare
Sector PE	48.94
Sector PE Fwd	22.07
Symbol	CNSY
Website	https://cerenome.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-44.22%
EV Sales Forward	1.42x
EV/Sales	2.43x
FCF yield	-80.51%
P/B ratio	2.21x
P/S ratio	5.21x
PS Forward	3.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-83.1%
Gross Profit	$-4.3M
Net Income	$-11.9M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-230.24%
Profit Margin	-230.24%
Profit Per Employee	$-426,107
ROA	-73.82
Roa5y	-66.17
ROCE	-157.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-68.38%
Cagr15y	-62.64%
Cagr1y	-79.86%
Cagr20y	-53.42%
Cagr3y	-59.69%
Cagr5y	-65.02%
EPS Growth Quarters	1
EPS Growth Years	11
Revenue Growth	-0.46x
Revenue Growth Q	-2.93x
Revenue Growth Years	0x
Revenue Growth3 Y	92.19x
Revenue Growth5 Y	94.74x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.32
Assets	$19.9M
Cash	$15.1M
Current Assets	$18M
Current Liabilities	$8M
Debt	$725,000
Debt Equity	$0.06
Equity	$12M
Interest Coverage	-1,110.6
Liabilities	$8M
Long Term Assets	$1.9M
Long Term Liabilities	$0
Net Cash	$14.4M
Net Cash By Market Cap	$53.33
Net Cash Growth	46.42%
Net Debt Equity	$-1.2
Tangible Book Value	$11.3M
Tangible Book Value Per Share	$1.65
WACC	11.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.27
Net Working Capital	$-4.3M
Quick ratio	2.07
Working Capital	$10.1M
Working Capital Turnover	$1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1,157.41%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-79.84%
200-day SMA	8.12
3Y total return	-93.45%
50-day SMA	4.38
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.48%
All Time High	28,149,606.3
All Time High Change	-100%
All Time High Date	2005-12-19
All Time Low	2.9
All Time Low Change	32.07%
All Time Low Date	2026-04-07
ATR	0.31
Beta	1.42
Beta1y	2.15
Beta2y	1.41
Ch YTD	-70.1
High	3.96
High52	23.43
High52 Date	2025-10-06
High52ch	-83.65%
Low	3.77
Low52	2.9
Low52 Date	2026-04-07
Low52ch	32.07%
Ma50ch	-12.52%
Premarket Change Percent	-1.1
Premarket Price	$3.82
Premarket Volume	230
Price vs 200-day SMA	-52.84%
RSI	45.59
RSI Monthly	30.55
RSI Weekly	34.87
Sharpe ratio	-0.78x
Sortino ratio	-1.09
Total Return	-1,157.41%
Tr YTD	-70.1
Tr15y	-100%
Tr1m	-5.43%
Tr1w	-1.03%
Tr3m	-36.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	0
Analyst Ratings	Strong Buy
Operating Income	$-18.9M
Operating margin	-364.4
Price target	$36
Price Target Change	$840

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,456,434%
Float Percent	93.8%
Net Borrowing	650,000
Shares Insiders	0.96%
Shares Institutions	6.65%
Shares Out	6,883,106
Shares Qo Q	20.68%
Shares Yo Y	1,157.41%
Short Float	10.99%
Short Ratio	2.97
Short Shares	10.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-24.1M
Adjusted OCF	-23,255,000
Average Volume	116,827.5x
Bv Per Share	1.74
CAPEX	$-882,000
Ch10y	-100
Ch15y	-100
Ch1m	-5.43
Ch1w	-1.03
Ch1y	-79.84
Ch20y	-100
Ch3m	-36.17
Ch3y	-93.45
Ch5y	-99.48
Ch6m	-41.06
Change	-0.78%
Change From Open	1.32
Close	3.86
Days Gap	-2.07
Depreciation Amortization	395,000
Dollar Volume	261,535.4
Earnings Date	2026-08-14
EBIT	$-18.9M
EBITDA	$-18.5M
EPS	$-2.62
F Score	2
FCF	$-21.7M
FCF EV Yield	-172.5x
FCF Per Share	$-3.16
Financing CF	26,941,000
Fiscal Year End	December
Founded	1,996
Goodwill	372,000
Investing CF	-12,945,000
Is Primary Listing	1
Is Spac	No
Last Report Date	2026-03-31
Last Split Date	2026-04-02
Last Split Type	Reverse
Ma150	6.04
Ma150ch	-36.56%
Ma20	3.85
Ma20ch	-0.6%
Net CF	-6,845,000
Next Earnings Date	2026-08-14
Open	3.78
Position In Range	32.43
Post Close	3.83
Postmarket Change Percent	0.52
Postmarket Price	$3.85
Ppne	1,070,000
Pre Close	3.86
Price Date	2026-08-07
Ptbv Ratio	2.39
Relative Volume	0.58x
Revenue	5,182,000x
SBC By Revenue	46.58x
Share Based Comp	2,414,000
Tr20y	-100%
Tr6m	-41.05%
Us State	Texas
Volume	68,286
Z Score	-35.72

Cerenome, Inc. (CNSY)

Coverage state: Market snapshot only — no published research

Generate the first CNSY analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · CNSY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CNSY indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CNSY

Frequently asked questions